Summary & Overview
CPT 15202: Application of Skin Substitute Graft to Trunk/Extremities
Headline: New Guidance on Application of Skin Substitute Grafts for Small Wound Areas
Lead: CPT 15202 codes for the application of a skin substitute graft to the trunk, arms, or legs for wound areas of 100 square centimeters or less. The code is relevant to dermatology and surgical practices managing acute and chronic wounds, and it affects billing and coverage discussions nationally.
CPT 15202 represents a targeted procedure used when a skin substitute graft is applied to moderate-sized wounds on the trunk or extremities. It matters nationally because use of skin substitutes is increasing in wound care, affecting coding clarity, payer coverage decisions, and outpatient surgical workflows. Key payers addressed in this overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, BUCA, and Medicare.
Readers will learn: a concise definition of the code and clinical context; which major payers are considered in coverage conversations; common companion and related procedure codes; and typical settings where the service is performed. The summary highlights billing adjacency with related debridement and grafting codes and clarifies that CPT 15202 is specific to skin substitute application for wound areas up to 100 sq cm. Data not available in the input for service line specifics beyond Dermatology metadata.
CPT Code Overview
CPT 15202 describes the application of a skin substitute graft to the trunk, arms, or legs for a total wound surface area of 100 square centimeters or less. The code is used when a biologic or synthetic skin substitute is placed over a wound bed to promote healing and tissue regeneration. This procedure is performed within the Dermatology service line and is typically delivered in an Outpatient Hospital (POS 22) setting.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a non-healing chronic lower leg ulcer is evaluated in an outpatient hospital dermatology clinic (POS 22). After debridement and wound bed preparation by the attending clinician, a biologic skin substitute graft is applied to the wound site. The procedure covers a total wound surface area of 100 square centimeters or less. The clinical workflow includes pre-procedure wound assessment, informed consent, sterile application of the skin substitute graft, documentation of wound size and graft placement, and post-procedure wound care instructions with scheduled follow-up visits for graft assessment and possible repeat applications if required.
Coding Specifications
-
Modifier
59— Distinct Procedural ServiceUse when the application of the skin substitute graft is separate and distinct from other procedures performed at the same encounter, and the documentation supports that the graft application is unrelated to other services billed on the same day.
-
Modifier
76— Repeat Procedure or Service by Same Physician or Other Qualified Health Care ProfessionalUse when the same physician or qualified health care professional performs the identical procedure again on the same patient within the postoperative period or during a subsequent encounter, and documentation clarifies the reason for the repeat application.
-
Associated Provider Taxonomies
| Taxonomy Code | Specialty |
|---|---|
207ND0900X | Dermatology |
208600000X | Surgery |
207P00000X | Emergency Medicine Physician |
Related Diagnoses
-
L97.909— Non-pressure chronic ulcer of unspecified part of unspecified lower legRelevant as a common indication for application of a skin substitute graft to promote healing of a chronic lower extremity ulcer.
-
T81.31XA— Disruption of external operation (surgical) wound, not elsewhere classified, initial encounterRelevant when a post-surgical wound dehiscence necessitates application of a skin substitute graft for wound coverage and healing support.
-
S81.801A— Unspecified open wound, right lower leg, initial encounterRelevant as an acute open wound of the lower leg that may receive a skin substitute graft depending on wound characteristics.
-
L89.309— Pressure ulcer of unspecified buttock, stage 1Relevant as a pressure-related skin injury; while stage 1 is superficial, documentation of wound progression or compromise may lead to use of advanced wound therapies including skin substitutes in later stages or concurrent wounds.
-
L98.499— Non-pressure chronic ulcer of skin, unspecifiedRelevant as a general chronic skin ulcer diagnosis that may be treated with application of a skin substitute graft when conservative measures are insufficient.
Related CPT Codes
| CPT Code | Description | Clinical relationship to 15202 |
|---|---|---|
15201 | Application of skin substitute graft to trunk, arms, legs, total wound surface area 100 sq cm or less | Alternative code for the same category; appears duplicative in input but represents the same primary application level. |
15002 | Surgical preparation or creation of recipient site by excision of open wounds, burn eschar, or scar | May be performed immediately prior to 15202 when surgical preparation or excision of wound bed is required; commonly billed before application if performed. |
15100 | Split-thickness autograft, trunk, arms, legs; first 100 sq cm or less | Alternative grafting technique (autograft) that may be used instead of a skin substitute graft; represents a different surgical approach. |
11042 | Debridement, subcutaneous tissue (includes epidermis and dermis, if performed); first 20 sq cm or less | Wound debridement performed as part of wound bed preparation prior to application of a skin substitute; commonly used in the same encounter when debridement is clinically necessary. |
- Codes commonly used together:
11042(debridement) and15002(recipient site preparation) may precede15202in the clinical workflow.15100is an alternative to15202when autograft is chosen instead of a skin substitute.
National Reimbursement Benchmarks
Blue Cross Blue Shield national mean rate for CPT 15202 is $80.02, which matches the BUCA (average commercial) mean rate of $80.02. Medicare data for this code is not available in the input.
Dispersion across available payers is minimal: for both BCBS and BUCA the 25th, 50th, and 75th percentiles are $80.00, $80.00, and $80.00 respectively, indicating a zero-dollar interquartile range. Other national payers have no data in the input. The table and chart below present the full breakdown.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.